Cargando…
The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs
Inflammation is a natural defense process of the innate immune system, associated with the release of proinflammatory cytokines such as interleukin-1β, interleukin-6, interleukin-12 and TNFα; and enzymes including iNOS through the activation and nuclear translocation of NF-κB p65 due to the phosphor...
Autores principales: | Abdelazeem, Khalid N. M., Kalo, M. Zaher, Beer-Hammer, Sandra, Lang, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007722/ https://www.ncbi.nlm.nih.gov/pubmed/33782464 http://dx.doi.org/10.1038/s41598-021-86514-6 |
Ejemplares similares
-
Potential of the ellagic acid-derived gut microbiota metabolite – Urolithin A in gastrointestinal protection
por: Kujawska, Małgorzata, et al.
Publicado: (2020) -
Urolithins: The Colon Microbiota Metabolites as Endocrine Modulators: Prospects and Perspectives
por: Vini, Ravindran, et al.
Publicado: (2022) -
Urolithin B, a Gut Microbiota Metabolite, Reduced Susceptibility to Myocardial Arrhythmic Predisposition after Hypoxia
por: Huang, Xin, et al.
Publicado: (2022) -
The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B
por: Wang, Lixue, et al.
Publicado: (2023) -
Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases
por: Li, Kailin, et al.
Publicado: (2022)